These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12213572)

  • 21. Comparative proteome analysis of breast cancer and normal breast.
    Luo Y; Zhang J; Liu Y; Shaw AC; Wang X; Wu S; Zeng X; Chen J; Gao Y; Zheng D
    Mol Biotechnol; 2005 Mar; 29(3):233-44. PubMed ID: 15767701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basic fibroblast growth factor mediated growth inhibition in breast cancer cells is independent of ras signaling pathway.
    Fenig E; Szyper-Kravitz M; Yerushalmi R; Lahav M; Beery E; Wasserman L; Gutman H; Nordenberg J
    Oncol Rep; 2002; 9(4):875-7. PubMed ID: 12066225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation.
    Wieder R; Fenig E; Wang H; Wang Q; Paglin S; Menzel T; Gabrilove J; Fuks Z; Yahalom J
    J Cell Physiol; 1998 Dec; 177(3):411-25. PubMed ID: 9808150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
    Warmoes M; Lam SW; van der Groep P; Jaspers JE; Smolders YH; de Boer L; Pham TV; Piersma SR; Rottenberg S; Boven E; Jonkers J; van Diest PJ; Jimenez CR
    Oncotarget; 2016 Sep; 7(39):63537-63548. PubMed ID: 27566577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Functional proteomics in oncology: to understand more than to describe].
    Com E; Hondermarck H
    Med Sci (Paris); 2007 Mar; 23 Spec No 1():27-30. PubMed ID: 17669350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of EGF-mediated growth control and signal transduction using the MDA-MB-468 human breast cancer cell line.
    Buick RN; Filmus J; Church J
    Prog Clin Biol Res; 1990; 354A():179-91. PubMed ID: 2247487
    [No Abstract]   [Full Text] [Related]  

  • 27. Functional Interference in the Bone Marrow Microenvironment by Disseminated Breast Cancer Cells.
    Dhawan A; von Bonin M; Bray LJ; Freudenberg U; Pishali Bejestani E; Werner C; Hofbauer LC; Wobus M; Bornhäuser M
    Stem Cells; 2016 Aug; 34(8):2224-35. PubMed ID: 27090603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway.
    Wu ZJ; Li Y; Wu YZ; Wang Y; Nian WQ; Wang LL; Li LC; Luo HL; Wang DL
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):706-714. PubMed ID: 28272713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thioredoxin post-transcriptional regulation by H19 provides a new function to mRNA-like non-coding RNA.
    Lottin S; Vercoutter-Edouart AS; Adriaenssens E; Czeszak X; Lemoine J; Roudbaraki M; Coll J; Hondermarck H; Dugimont T; Curgy JJ
    Oncogene; 2002 Feb; 21(10):1625-31. PubMed ID: 11896592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Huaier Extract Inhibits Breast Cancer Progression Through a LncRNA-H19/MiR-675-5p Pathway.
    Wang J; Wang X; Chen T; Jiang L; Yang Q
    Cell Physiol Biochem; 2017; 44(2):581-593. PubMed ID: 29145193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular 14-3-3sigma protein: a potential mediator of epithelial-mesenchymal interactions.
    Hermeking H
    J Invest Dermatol; 2005 Jan; 124(1):ix-x. PubMed ID: 15654940
    [No Abstract]   [Full Text] [Related]  

  • 33. Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness.
    Shima H; Kida K; Adachi S; Yamada A; Sugae S; Narui K; Miyagi Y; Nishi M; Ryo A; Murata S; Taniguchi H; Ichikawa Y; Ishikawa T; Endo I
    Breast Cancer Res Treat; 2018 Aug; 170(3):507-516. PubMed ID: 29693231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.
    Heo MJ; Yun J; Kim SG
    Arch Pharm Res; 2019 Jan; 42(1):48-62. PubMed ID: 30610616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas.
    Olsen L; Campos B; Winther O; Sgroi DC; Karger BL; Brusic V
    BMC Med Genomics; 2014; 7 Suppl 3(Suppl 3):S2. PubMed ID: 25521819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of promoter hypermethylation during breast cancer development.
    Lehmann U; Länger F; Feist H; Glöckner S; Hasemeier B; Kreipe H
    Am J Pathol; 2002 Feb; 160(2):605-12. PubMed ID: 11839581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.
    Milioli HH; Santos Sousa K; Kaviski R; Dos Santos Oliveira NC; De Andrade Urban C; De Lima RS; Cavalli IJ; De Souza Fonseca Ribeiro EM
    Cancer Genomics Proteomics; 2015; 12(2):89-101. PubMed ID: 25770193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "good-cop bad-cop" TGF-beta role in breast cancer modulated by non-coding RNAs.
    Gulei D; Mehterov N; Ling H; Stanta G; Braicu C; Berindan-Neagoe I
    Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1661-1675. PubMed ID: 28411077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stratifin-induced matrix metalloproteinase-1 in fibroblast is mediated by c-fos and p38 mitogen-activated protein kinase activation.
    Lam E; Kilani RT; Li Y; Tredget EE; Ghahary A
    J Invest Dermatol; 2005 Aug; 125(2):230-8. PubMed ID: 16098031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological function of long noncoding RNA snaR in HER2-positive breast cancer cells.
    Lee J; Park HY; Kim WW; Lee SJ; Jeong JH; Kang SH; Jung JH; Chae YS
    Tumour Biol; 2017 Jun; 39(6):1010428317707374. PubMed ID: 28653903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.